Copyright
©The Author(s) 2025.
World J Clin Cases. Oct 16, 2025; 13(29): 108582
Published online Oct 16, 2025. doi: 10.12998/wjcc.v13.i29.108582
Published online Oct 16, 2025. doi: 10.12998/wjcc.v13.i29.108582
Figure 2 The clinical course of our case.
Ag: Antigen; β-DG: Beta-D-glucan; CMV: Cytomegalovirus; CPFG: Caspofungin; CRP: C-reactive protein; DNA: Deoxyribonucleic acid; DRPM: Doripenem; FLCZ: Fluconazole; GCV: Ganciclovir; LVFX: Levofloxacin; LZD: Linezolid; MEPM: Meropenem; PIPC/TAZ: Piperacillin/tazobactam; P. jirovecii: Pneumocystis jirovecii; PTM: Pentamidine; ST: Sulfamethoxazole and trimethoprim; WBC: White blood cell.
- Citation: Usuda D, Furukawa D, Imaizumi R, Ono R, Kaneoka Y, Nakajima E, Sugawara Y, Shimizu R, Sakurai R, Matsubara S, Tanaka R, Suzuki M, Shimozawa S, Hotchi Y, Osugi I, Katou R, Ito S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Nomura T, Sugita M. Purpureocillium lilacinum: A minireview. World J Clin Cases 2025; 13(29): 108582
- URL: https://www.wjgnet.com/2307-8960/full/v13/i29/108582.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i29.108582